These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 15155524

  • 1. Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism.
    Picconi B, Centonze D, Rossi S, Bernardi G, Calabresi P.
    Brain; 2004 Jul; 127(Pt 7):1661-9. PubMed ID: 15155524
    [Abstract] [Full Text] [Related]

  • 2. Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease.
    Sciaccaluga M, Mazzocchetti P, Bastioli G, Ghiglieri V, Cardinale A, Mosci P, Caccia C, Keywood C, Melloni E, Padoani G, Vailati S, Picconi B, Calabresi P, Tozzi A.
    Neuropharmacology; 2020 Jun 15; 170():108024. PubMed ID: 32142791
    [Abstract] [Full Text] [Related]

  • 3. Modulation by Trace Amine-Associated Receptor 1 of Experimental Parkinsonism, L-DOPA Responsivity, and Glutamatergic Neurotransmission.
    Alvarsson A, Zhang X, Stan TL, Schintu N, Kadkhodaei B, Millan MJ, Perlmann T, Svenningsson P.
    J Neurosci; 2015 Oct 14; 35(41):14057-69. PubMed ID: 26468205
    [Abstract] [Full Text] [Related]

  • 4. Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism.
    Centonze D, Gubellini P, Rossi S, Picconi B, Pisani A, Bernardi G, Calabresi P, Baunez C.
    Neuroscience; 2005 Oct 14; 133(3):831-40. PubMed ID: 15893432
    [Abstract] [Full Text] [Related]

  • 5. Peculiarities of L: -DOPA treatment of Parkinson's disease.
    Kostrzewa RM, Nowak P, Kostrzewa JP, Kostrzewa RA, Brus R.
    Amino Acids; 2005 Mar 14; 28(2):157-64. PubMed ID: 15750845
    [Abstract] [Full Text] [Related]

  • 6. Dopamine receptor cooperativity synergistically drives dyskinesia, motor behavior, and striatal GABA neurotransmission in hemiparkinsonian rats.
    Kiessling CY, Lanza K, Feinberg E, Bishop C.
    Neuropharmacology; 2020 Sep 01; 174():108138. PubMed ID: 32492451
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
    Ravenscroft P, Chalon S, Brotchie JM, Crossman AR.
    Exp Neurol; 2004 Jan 01; 185(1):36-46. PubMed ID: 14697317
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment.
    Picconi B, Pisani A, Centonze D, Battaglia G, Storto M, Nicoletti F, Bernardi G, Calabresi P.
    Brain; 2002 Dec 01; 125(Pt 12):2635-45. PubMed ID: 12429591
    [Abstract] [Full Text] [Related]

  • 16. Liposomal Form of L-Dopa and SH-Sy5y Cell-Derived Exosomes Modulate the Tyrosine Hydroxylase/Dopamine Receptor D2 Signaling Pathway in Parkinson's Rat Models.
    Zarrin P, Dehghani Ashkezari M, Seifati SM.
    J Mol Neurosci; 2021 Dec 01; 71(12):2583-2592. PubMed ID: 34125397
    [Abstract] [Full Text] [Related]

  • 17. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
    Mela F, Marti M, Dekundy A, Danysz W, Morari M, Cenci MA.
    J Neurochem; 2007 Apr 01; 101(2):483-97. PubMed ID: 17359492
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. GABA storage and release in the medial globus pallidus in L-DOPA-induced dyskinesia priming.
    Nishijima H, Mori F, Arai A, Zhu G, Wakabayashi K, Okada M, Ueno S, Ichinohe N, Suzuki C, Kon T, Tomiyama M.
    Neurobiol Dis; 2020 Sep 01; 143():104979. PubMed ID: 32590036
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.